Skip to main content
Signal8

Loew Caroline

SEC insider (Form 3/4/5 filer). CIK 0001989488. Chief Executive Officer at Mural Oncology plc (MURA). 5 reported Form 4/5 transactions since Sep 2024; latest on Dec 5, 2025. Located in DUBLIN 2, L2.

Companies Loew Caroline has filed insider reports for

  • Mural Oncology plc (MURA): Director, Officer, Chief Executive Officer
Loew Caroline profile photo

Loew Caroline

CIK: 0001989488

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mural Oncology plc logo
MURA

Mural Oncology plc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Dec 5, 2025
    Disposition
    Direct
    293.1K shares-
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Jul 7, 2025
    Sale
    Direct
    12.5K shares at avg. $2.43$30K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Mar 4, 2025
    Sale
    Direct
    4.3K shares at avg. $3.36$14K
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Mar 3, 2025
    Award
    Direct
    72.3K shares-
  • Mural Oncology plc logo
    MURA

    Mural Oncology plc

    Dec 17, 2024
    Sale
    Direct
    2.8K shares at avg. $3.40$9K

1-5 of 5